IQQE:XETRA:XETRA-iShares MSCI Emerging Markets UCITS Dist (EUR)

ETF | Others |

Last Closing

USD 40.769

Change

+0.23 (+0.57)%

Market Cap

USD 4.50B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.41 (+0.79%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.13 (+0.77%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.97%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.21 (+0.73%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.41%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.01%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.78%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.19 (+0.20%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.48 (+0.27%)

USD 80.38B

ETFs Containing IQQE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.75% 69% C- 69% C-
Dividend Return -3.20% 2% F 1% F
Total Return 10.55% 54% F 56% F
Trailing 12 Months  
Capital Gain 17.79% 50% F 53% F
Dividend Return -3.31% 2% F 1% F
Total Return 14.47% 42% F 46% F
Trailing 5 Years  
Capital Gain 18.14% 39% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.14% 38% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain 2.31% N/A N/A 40% F
Dividend Return 2.84% N/A N/A 41% F
Total Return 0.54% N/A N/A 26% F
Risk Return Profile  
Volatility (Standard Deviation) 14.09% N/A N/A 52% F
Risk Adjusted Return 20.18% N/A N/A 36% F
Market Capitalization 4.50B 95% A 84% B

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike